Quantum Cyber N.V. (QUCY) vs Telomir Pharmaceuticals (TELO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 12, 2026.
Summary
Telomir Pharmaceuticals (TELO) has outperformed Quantum Cyber N.V. (QUCY) over the past year, losing 30.0% versus a loss of 34.4%. Quantum Cyber N.V. is the larger company by market cap ($86.6 million vs $81.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QUCY | TELO |
|---|---|---|
| Share price | $1.03 | $1.10 |
| Market cap | $86.59M | $80.98M |
| 1-day change | -23.70% | -1.79% |
| YTD return | -8.04% | -15.79% |
| 1-year return | -34.39% | -30.00% |
| EPS (TTM) | $-2.41 | $-1.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.93 | $1.75 |
| 52-week low | $0.30 | $0.888 |
| Distance from 52-week high | -79.11% | -37.14% |
| Analyst consensus | none | none |
| Avg. price target upside | +773.79% | +263.64% |
| Average volume | 689.09K | 98.53K |
| Shares outstanding | 84.07M | 73.62M |
| Employees | 10 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Quantum Cyber N.V.
QUCY stock →Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
About Telomir Pharmaceuticals
TELO stock →Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria.
Health Care · Biotechnology: Pharmaceutical Preparations
QUCY vs TELO FAQ
Which is bigger, Quantum Cyber N.V. or Telomir Pharmaceuticals?
Quantum Cyber N.V. (QUCY) is larger, with a market capitalization of $86.59M compared with $80.98M for Telomir Pharmaceuticals (TELO).
Which stock has performed better over the past year, QUCY or TELO?
TELO returned -30.00% over the past 12 months, compared with -34.39% for QUCY (price return, excluding dividends). Past performance does not predict future results.
Are Quantum Cyber N.V. and Telomir Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.